News Preview
Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October
Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to consider issuing non-convertible debentures (NCDs) worth up to ₹15,000 crore.
The proposed issuance is to fund a bridge loan for acquiring Organon & Co, with the meeting set to approve the issuance.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.